Establishment and Performance Evaluation of Multiplex PCR-Dipstick DNA Chromatography for Mycoplasma pneumoniae and Chlamydia pneumoniae Rapid Detection
Related Experiment Video
Updated: Jul 27, 2026
Multiplex PCR and Reverse Line Blot Hybridization Assay mPCR/RLB
Published on: August 6, 2011
Liuyang Hu1, Xiuri Wang2, Donglin Cao3
1Department of Laboratory Medicine, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning 530016, China.
Methods:
Nasopharyngeal swab samples of 300 children with an acute respiratory tract infection were detected by a multiplex PCR-dipstick chromatography assay, and the results were compared with the DNA sequencing and serum IgM antibody assay.
Results:
A multiplex PCR-dipstick DNA assay can specifically detect Mycoplasma pneumoniae and Chlamydia pneumoniae and shows a good specificity, with a minimum detection limit of 10 CFU/mL, respectively. Using DNA sequencing results as the gold standard, the sensitivity, specificity, positive predictive value, and negative predictive value of the multiplex PCR-dipstick DNA chromatography assay for the diagnosis of Mycoplasma pneumoniae were 96.61%, 100%, 100%, and 99.18% respectively, and those of Chlamydia pneumoniae were 95.24%, 100%, 100%, and 99.64% respectively. There was no statistical significance MP and CP diagnosis by the multiplex PCR-dipstick DNA assay and DNA sequencing (MP: P = 0.5; CP: P = 1.0), and the two assays had very high statistical consistency (MP: kappa = 0.979; CP: kappa = 0.974). The positive rate of the multiplex PCR-dipstick chromatography assay was significantly higher than that of the serum IgM antibody assay, with MP (17.7% vs. 13.3%), CP (5.7% vs. 3.3%), and mixed infection of MP and CP (1.3% vs. 0.67%).
Conclusions:
A multiplex PCR-dipstick chromatography assay was successfully established for the joint detection of Mycoplasma pneumoniae and Chlamydia pneumoniae within 2 hours. It is simple, fast, sensitive, accurate, cost-effective with good diagnostic performance, which can be used for small laboratories and point-of-care diagnosis.
Insights
A new multiplex PCR-dipstick assay accurately detects Mycoplasma pneumoniae and Chlamydia pneumoniae in children with respiratory infections. This rapid, cost-effective method offers high sensitivity and specificity for point-of-care diagnosis.
Area of Science:
- Microbiology
- Infectious Diseases
- Diagnostic Assays
Background:
- Acute respiratory tract infections (ARTIs) in children are frequently caused by bacterial pathogens.
- Accurate and rapid diagnosis of specific pathogens like Mycoplasma pneumoniae (MP) and Chlamydia pneumoniae (CP) is crucial for effective treatment.
- Existing diagnostic methods may have limitations in speed, sensitivity, or accessibility.
Purpose of the Study:
- To establish and evaluate a novel multiplex PCR-dipstick chromatography assay for the simultaneous detection of MP and CP.
- To assess the diagnostic performance of this assay compared to DNA sequencing and serum IgM antibody assays.
- To determine the clinical utility of the assay for diagnosing pediatric respiratory infections.
Main Methods:
- Nasopharyngeal swab samples from 300 children with ARTIs were analyzed.
- A multiplex PCR-dipstick chromatography assay was developed for detecting MP and CP.
- Results were compared against DNA sequencing (gold standard) and serum IgM antibody assays.
Main Results:
- The multiplex PCR-dipstick assay demonstrated high sensitivity (96.61% for MP, 95.24% for CP) and specificity (100% for both).
- The assay showed excellent agreement with DNA sequencing (kappa values > 0.97) and no statistically significant difference in diagnosis.
- The positive detection rate for MP and CP was significantly higher with the PCR-dipstick assay compared to the serum IgM antibody assay.
Conclusions:
- A simple, fast, sensitive, and accurate multiplex PCR-dipstick assay for joint detection of MP and CP was successfully established.
- The assay exhibits good diagnostic performance and cost-effectiveness.
- This method is suitable for small laboratories and point-of-care diagnosis of pediatric respiratory infections caused by MP and CP.
